- Home
- PHOS vs OSUR Comparison
PHOS vs OSUR Comparison
Compare PHOS & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHOS | OSUR |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.7M | 254.5M |
| IPO Year | 2010 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PHOS | OSUR |
|---|---|---|
| Price | $11.99 | $4.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 23.5K | ★ 493.0K |
| Earning Date | 11-28-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | N/A | $6.16 |
| Revenue Next Year | N/A | $9.09 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.23 | $2.08 |
| 52 Week High | $21.30 | $4.58 |
Technical Indicators
Market Signals| Indicator | PHOS | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 36.20 | 60.69 |
| Support Level | N/A | $3.67 |
| Resistance Level | $15.26 | $4.16 |
| Average True Range (ATR) | 1.00 | 0.18 |
| MACD | -0.20 | 0.01 |
| Stochastic Oscillator | 21.72 | 88.03 |
Price Performance
Historical ComparisonAbout PHOS First Phosphate Corp. American Depositary Shares
First Phosphate Corp owns and is developing igneous rock phosphate mineral properties in the Saguenay Region of Quebec for the production of phosphoric acid for the production of cathode active material for use in lithium iron phosphate (LPF) batteries for the electric vehicle industry.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.